Efficacy and safety of BI 425809 in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme
Autor: | G. Wunderlich, Z. Blahova, S. Hake, S. Ikezawa, S. Marder, P. Falkai, J. Krystal |
---|---|
Rok vydání: | 2022 |
Zdroj: | Neuroscience Applied. 1:100342 |
ISSN: | 2772-4085 |
Databáze: | OpenAIRE |
Externí odkaz: |